Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

被引:324
作者
Benn, Marianne [1 ,2 ,3 ]
Watts, Gerald F. [4 ]
Tybjaerg-Hansen, Anne [2 ,3 ,5 ]
Nordestgaard, Borge G. [2 ,3 ,6 ]
机构
[1] Copenhagen Univ Hosp, Gentofte Hosp, Dept Clin Biochem, Kildegardsvej 28, DK-2900 Gentofte, Denmark
[2] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Kildegardsvej 28, DK-2900 Gentofte, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Lipid Disorders Clin,Cardiovasc Med, Crawley, Australia
[5] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Kildegardsvej 28, DK-2900 Copenhagen, Denmark
[6] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Kildegardsvej 28, DK-2900 Copenhagen, Denmark
关键词
Familial hypercholesterolaemia; Coronary artery disease; Ischaemic heart disease; Myocardial infarction; Low-density lipoprotein; General population; LDLR mutation; APOB mutation; ISCHEMIC-HEART-DISEASE; DENSITY-LIPOPROTEIN-RECEPTOR; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; CLINICAL-DIAGNOSIS; APOLIPOPROTEIN-B; GENETIC CAUSES; CHOLESTEROL; GUIDANCE;
D O I
10.1093/eurheartj/ehw028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Ideally, familial hypercholesterolaemia (FH) is diagnosed by testing for mutations that decrease the catabolism of low-density lipoprotein (LDL) cholesterol; however, genetic testing is not universally available. The aim of the present study was to assess the frequency and predictors of FH causing mutations in 98 098 participants from the general population, the Copenhagen General Population Study. Methods and results We genotyped for LDLR[W23X; W66G; W556S] and APOB[R3500Q] accounting for 38.7% of pathogenic FH mutations in Copenhagen. Clinical FH assessment excluded mutation information. The prevalence of the four FH mutations was 0.18% (1: 565), suggesting a total prevalence of FH mutations of 0.46% (1: 217). Using the Dutch Lipid Clinic Network (DLCN) criteria, odds ratios for an FH mutation were 439 (95% CI: 170-1 138) for definite FH, 90 (53-152) for probable FH, and 18 (13-25) for possible FH vs. unlikely FH. Using the Simon Broome criteria, the odds ratio was 27 (20-36) for possible vs. unlikely FH, and using the Make Early Diagnosis to Prevent Early Death (MEDPED) criteria, 40 (28-58) for probable vs. unlikely FH. Odds ratios for an FH mutation were 17 (9 - 31) for LDL-cholesterol of 4 - 4.9 mmol/L, 69 (37 - 126) for LDL-cholesterol of 5 - 5.9 mmol/L, 132 (66 - 263) for LDL-cholesterol of 6 - 6.9 mmol/L, 264 (109 - 637) for LDL-cholesterol of 7 - 7.9 mmol/L, and 320 (129-798) for LDL-cholesterol above 7.9 mmol/L vs. LDL-cholesterol below 4 mmol/L. The most optimal threshold for LDL-cholesterol concentration to discriminate between mutation carriers and non-carriers was 4.4 mmol/L. Conclusion Familial hypercholesterolaemia-causing mutations are estimated to occur in 1: 217 in the general population and are best identified by a definite or probable phenotypic diagnosis of FH based on the DLCN criteria or an LDL-cholesterol above 4.4 mmol/L.
引用
收藏
页码:1384 / 1394
页数:11
相关论文
共 37 条
[1]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[3]   Familial hypercholesterolemia and coronary heart disease: A HuGE association review [J].
Austin, MA ;
Hutter, CM ;
Zimmern, RL ;
Humphries, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :421-429
[4]   Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review [J].
Austin, MA ;
Hutter, CM ;
Zimmern, RL ;
Humphries, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :407-420
[5]   Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication (vol 97, pg 3956) [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12) :4758-4759
[6]   Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) :3956-3964
[7]   Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia [J].
Civeira, Fernando ;
Ros, Emilio ;
Jarauta, Estibaliz ;
Plana, Nuria ;
Zambon, Daniel ;
Puzo, Jose ;
Martinez de Esteban, Juan P. ;
Ferrando, Juan ;
Zabala, Sergio ;
Almagro, Fatima ;
Gimeno, Jose A. ;
Masana, Luis ;
Pocovi, Miguel .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (09) :1187-1193
[8]   Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society [J].
Cuchel, Marina ;
Bruckert, Eric ;
Ginsberg, Henry N. ;
Raal, Frederick J. ;
Santos, Raul D. ;
Hegele, Robert A. ;
Kuivenhoven, Jan Albert ;
Nordestgaard, Borge G. ;
Descamps, Olivier S. ;
Steinhagen-Thiessen, Elisabeth ;
Tybjrg-Hansen, Anne ;
Watts, Gerald F. ;
Averna, Maurizio ;
Boileau, Catherine ;
Boren, Jan ;
Catapano, Alberico L. ;
Defesche, Joep C. ;
Hovingh, G. Kees ;
Humphries, Steve E. ;
Kovanen, Petri T. ;
Masana, Luis ;
Pajukanta, Paivi ;
Parhofer, Klaus G. ;
Ray, Kausik K. ;
Stalenhoef, Anton F. H. ;
Stroes, Erik ;
Taskinen, Marja-Riitta ;
Wiegman, Albert ;
Wiklund, Olov ;
Chapman, M. John .
EUROPEAN HEART JOURNAL, 2014, 35 (32) :2146-U100
[9]   The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population [J].
Damgaard, D ;
Larsen, ML ;
Nissen, PH ;
Jensen, JA ;
Jensen, HK ;
Soerensen, VR ;
Jensen, LG ;
Faergeman, O .
ATHEROSCLEROSIS, 2005, 180 (01) :155-160
[10]   Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction [J].
Do, Ron ;
Stitziel, Nathan O. ;
Won, Hong-Hee ;
Jorgensen, Anders Berg ;
Duga, Stefano ;
Merlini, Pier Angelica ;
Kiezun, Adam ;
Farrall, Martin ;
Goel, Anuj ;
Zuk, Or ;
Guella, Illaria ;
Asselta, Rosanna ;
Lange, Leslie A. ;
Peloso, Gina M. ;
Auer, Paul L. ;
Girelli, Domenico ;
Martinelli, Nicola ;
Farlow, Deborah N. ;
DePristo, Mark A. ;
Roberts, Robert ;
Stewart, Alexander F. R. ;
Saleheen, Danish ;
Danesh, John ;
Epstein, Stephen E. ;
Sivapalaratnam, Suthesh ;
Hovingh, G. Kees ;
Kastelein, John J. ;
Samani, Nilesh J. ;
Schunkert, Heribert ;
Erdmann, Jeanette ;
Shah, Svati H. ;
Kraus, William E. ;
Davies, Robert ;
Nikpay, Majid ;
Johansen, Christopher T. ;
Wang, Jian ;
Hegele, Robert A. ;
Hechter, Eliana ;
Marz, Winfried ;
Kleber, Marcus E. ;
Huang, Jie ;
Johnson, Andrew D. ;
Li, Mingyao ;
Burke, Greg L. ;
Gross, Myron ;
Liu, Yongmei ;
Assimes, Themistocles L. ;
Heiss, Gerardo ;
Lange, Ethan M. ;
Folsom, Aaron R. .
NATURE, 2015, 518 (7537) :102-+